OVERVIEW

at a Glance

 

 •Oneness has been established since 2008 with dedication to developing first-in-class and best-in-class new drugs for chronic dermatological or immunological diseases.

 •The pipelines consists of multiple projects across all clinical stages where multiple milestones and approvals will be achieved globally in short-to-mid term.